Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung‐Hung Su, Jia‐Horng Kao, Chi‐Yi Chen et al.|Liver International|2016

Cited by 221